Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Turkish Journal of Chemistry|March 28, 2024
Recent advances and applications of nanostructured membranes in water purificationDidem Aydin, İlkay Hilal Gübbük, Mustafa Ersöz
Membranes|July 27, 2026
From Atomic Channels to Deployable Membranes: A Design-Oriented Framework for Graphene Oxide Transport, Functionalization, and ScalabilityAwad Alzebair, Didem Aydin, İlkay Hilal Gübbük, et al.
Environmental Science and Pollution Research International|July 2, 2024
Enhancing visible light photocatalytic activity of holmium doped g-C3N4 and DFT theoretical insightsAdem Yavuz, Didem Aydin, Besime Disli, et al.
Future Oncology (London, England)|April 13, 2026
Patterns of care in relapsed/refractory multiple myeloma in China: a real-world physician survey studyDi Wu, Bhavna Murali, Otavio Clark, et al.
Cancer Biotherapy & Radiopharmaceuticals|June 30, 2007
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptakeMurat Tuncel, Didem Aydin, Elif Yaman, et al.
Cancer Biotherapy & Radiopharmaceuticals|August 8, 2007
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptakeMurat Tuncel, Didem Aydin, Elif Yaman, et al.
Current Medical Research and Opinion|December 11, 2023
A matching-adjusted indirect comparison of the efficacy of elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myelomaIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.
Leukemia & Lymphoma|February 13, 2024
A matching-adjusted indirect comparison of the efficacy of elranatamab versus teclistamab in patients with triple-class exposed/refractory multiple myelomaIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.
Blood Cancer Journal|July 17, 2023
Global disparities in patients with multiple myeloma: a rapid evidence assessmentMaria-Victoria Mateos, Sikander Ailawadhi, Luciano J Costa, et al.
Journal of Comparative Effectiveness Research|April 7, 2025
Elranatamab versus physician's choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparisonIsha Mol, Yannan Hu, Thomas W LeBlanc, et al.
Pageof 2